Microscopic disease extension in three dimensions for non-small-cell lung cancer: Development of a prediction model using pathology-validated positron emission tomography and computed tomography features

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 448-456

  Van Loon, Judith ^a   Siedschlag, Christian ^c   Stroom, Joep ^c   Blauwgeers, Hans ^d   Van Suylen, Robert Jan ^b   Knegjens, Joost ^c   Rossi, Maddalena ^c   Van Baardwijk, Angela ^a   Boersma, Liesbeth ^a   Klomp, Houke ^c   Vogel, Wouter ^c   Burgers, Sjaak ^c   Gilhuijs, Kenneth ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Clinical target volume margins; Non small cell lung cancer; Pathology validation; Target definition

Indexed keywords

AREA UNDER THE CURVES; CLINICAL TARGET VOLUMES; COMPUTED TOMOGRAPHY; EFFECTIVE DIAMETER; GROSS TUMOR VOLUME; IMAGE-BASED; MULTI VARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSIONS; NON SMALL CELL LUNG CANCER; PRE-TREATMENT; PREDICTION MODEL; RADIOTHERAPY PLANNING; RISK FACTORS; THREE DIMENSIONS; TISSUE DEFORMATIONS; TWO PARAMETER;

BIOLOGICAL ORGANS; CELLS; COMPUTERIZED TOMOGRAPHY; DISEASES; FORECASTING; MATHEMATICAL MODELS; MULTIVARIANT ANALYSIS; PATHOLOGY; POSITRONS; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SCINTISCANNING; CANCER SIZE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; MALE; MICROSCOPIC DISEASE EXTENSION; MICROSCOPY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NETHERLANDS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REGRESSION ANALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 83955166004     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.001     Document Type: Article

References (31)

1. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study J Clin Oncol 23 2005 5910 5917
2. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
3. P. Zatloukal, L. Petruzelka, and M. Zemanova Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study Lung Cancer 46 2004 87 98
4. J. Belderbos, W. Heemsbergen, and M. Hoogeman Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy Radiother Oncol 75 2005 157 164
5. N.P. Rowell, and N.P. O'Rourke Concurrent chemoradiotherapy in non-small cell lung cancer Cochrane Database Syst Rev 2004 CD002140
6. I.S. Grills, D. Yan, and A.A. Martinez Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation Int J Radiat Oncol Biol Phys 57 2003 875 890
7. A. van Der Wel, S. Nijsten, and M. Hochstenbag Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655
8. J.S. Belderbos, W.D. Heemsbergen, and K. De Jaeger Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134
9. J. Wulf, U. Haedinger, and U. Oppitz Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients Int J Radiat Oncol Biol Phys 60 2004 186 196
10. C. Greco, K. Rosenzweig, and G.L. Cascini Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung Cancer 57 2007 125 134
11. S. Senan, D. De Ruysscher, and P. Giraud Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer Radiother Oncol 71 2004 139 146
12. R.J. Steenbakkers, J.C. Duppen, and I. Fitton Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: A 'Big Brother' evaluation Radiother Oncol 77 2005 182 190
13. Measurements ICoRUa. International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50). Bethesda; 1999.
14. R. Chan, Y. He, and A. Haque Computed tomographic-pathologic correlation of gross tumor volume and clinical target volume in non-small cell lung cancer: A pilot experience Arch Pathol Lab Med 125 2001 1469 1472
15. P. Giraud, M. Antoine, and A. Larrouy Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning Int J Radiat Oncol Biol Phys 48 2000 1015 1024
16. I.S. Grills, D.L. Fitch, and N.S. Goldstein Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy Int J Radiat Oncol Biol Phys 69 2007 334 341
17. W.L. Li, J.M. Yu, and G.H. Liu [A comparative study on radiology and pathology target volume in non-small-cell lung cancer.] Zhonghua Zhong Liu Za Zhi 25 2003 566 568
18. J. Stroom, H. Blaauwgeers, and A. van Baardwijk Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors Int J Radiat Oncol Biol Phys 69 2007 267 275
19. C. Siedschlag, J. van Loon, and A. van Baardwijk Analysis of the relative deformation of lung lobes before and after surgery in patients with NSCLC Phys Med Biol 54 2009 5483 5492
20. Q.C. Black, I.S. Grills, and L.L. Kestin Defining a radiotherapy target with positron emission tomography Int J Radiat Oncol Biol Phys 60 2004 1272 1282
21. Y.E. Erdi, O. Mawlawi, and S.M. Larson Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 1997 2505 2509
22. R. Boellaard, W.J. Oyen, and C.J. Hoekstra The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2008 2320 2333
23. M. Ollers, G. Bosmans, and A. van Baardwijk The integration of PET-CT scans from different hospitals into radiotherapy treatment planning Radiother Oncol 87 2008 142 146
24. K.G. Gilhuijs, M.L. Giger, and U. Bick Computerized analysis of breast lesions in three dimensions using dynamic magnetic-resonance imaging Med Phys 25 1998 1647 1654
25. M. Goitein, and T.E. Schultheiss Strategies for treating possible tumor extension: Some theoretical considerations Int J Radiat Oncol Biol Phys 11 1985 1519 1528
26. S. Webb, and A.E. Nahum A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density Phys Med Biol 38 1993 653 666
27. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
28. H.M. Yu, Y.F. Liu, and M. Hou Evaluation of gross tumor size using CT, (18)F-FDG PET, integrated (18)F-FDG PET/CT and pathological analysis in non-small cell lung cancer Eur J Radiol 72 2009 104 113
29. A. van Baardwijk, G. Bosmans, and L. Boersma PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat Oncol Biol Phys 68 2007 771 778
30. C.B. Caldwell, K. Mah, and M. Skinner Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int J Radiat Oncol Biol Phys 55 2003 1381 1393
31. N.S. Goldstein, M. Ferkowicz, and L. Kestin Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens Am J Clin Pathol 120 2003 720 724